The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in respiratory illness:

PROTOCOL: EBO-301 (MACrO2) (PI: DR RACHEL THOMSON)

Protocol Title: A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2).

Lay Title: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease.

Click here for more information

 

PROTOCOL: INS416 (ENCORE) (PI: DR RACHEL THOMSON)

Protocol Title: A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)

Lay Title: Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (ENCORE)

Click here for more information

 

PROTOCOL: IM027-068 (PI: Dr Katherine Semple)

Protocol Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Lay Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Click here for more information

 

 

 

RETURN TO CLINICAL TRIALS PAGE